FDA Warns Curaleaf about CBD Marketing Claims

WARNING LETTER VIA OVERNIGHT DELIVERY RETURN RECEIPT REQUESTED RE: 579289 July 22, 2019 Dear Joseph Lusardi: This letter is to advise you that the U.S. Food and Drug Administration...
- July 23rd, 2019 at 10:15 am